No Data
No Data
H.C. Wainwright Maintains Allogene Therapeutics(ALLO.US) With Buy Rating, Cuts Target Price to $8
HC Wainwright & Co. Maintains Buy on Allogene Therapeutics, Lowers Price Target to $8
Insider Sale: SVP of $ALLO Sells 5,488 Shares
Allogene Therapeutics Management to Meet Virtually With Truist
Allogene Therapeutics (ALLO) Receives a Buy From Oppenheimer
Stifel Maintains Allogene Therapeutics(ALLO.US) With Hold Rating, Cuts Target Price to $4
74950747 : $LOTTERY COM C/WTS (TO PUR COM) (LTRYW.US)$